Forty years ago, a handful of doctors in Spain performed the country's first liver transplant — an operation so complex that most patients survived only a decade. Today, Spain's liver transplant program is not just saving lives; it's generating more wealth than it costs, according to a groundbreaking new study.
Researchers from Pompeu Fabra University, the National Transplant Organization, and Vall d'Hebron University Hospital analyzed four decades of transplant data, from 1984 to 2024. Their findings, published in the journal Health Economics Review, show that liver transplant patients now contribute at least 100 million euros per year to the Spanish economy. That's more than the annual investment of roughly 75 million euros — or 90 million if you include lifelong medication costs.
The turnaround began in the early 2000s, when costs and economic benefits finally balanced out. Today, the balance is clearly positive.
"Thanks to gradual technological advances, an increasing number of working-age transplant recipients have survived, and their income has exceeded the costs of new transplants and immunosuppressive treatments in each of the past 15 years, with an increasingly larger margin," the researchers noted.
The numbers tell a striking story. In the 1980s, a liver transplant patient could expect to gain about 10 extra years of life. Today, adults gain 16 to 20 years, while children gain 21 to 29 years, thanks to advances in pediatric surgery. About 1,200 liver transplants are now performed in Spain each year, compared to just a few dozen in the mid-1980s.
Spain already boasts one of the world's highest organ donation rates — 52.6 donors per million people — making it a global benchmark for transplant systems.
The researchers say the positive trend could continue if new technologies further improve survival rates and reduce the need for repeat transplants. Even older patients, they note, may contribute more to society in years to come as life expectancy and quality of life continue to improve.
Lead researcher Gemma Piella from Pompeu Fabra University led the study alongside Gloria de la Rosa from the National Transplant Organization and Concepción Gómez Gavara, now affiliated with Hospital Clínic de Barcelona. Other contributors included researchers from the University of Barcelona, Vall d'Hebron University Hospital, and the University of Badajoz.
Forty years after that first pioneering operation, Spain's transplant program has quietly become a model — not just for medicine, but for what happens when public investment in health pays off in every sense of the word.